Encourage • Empower • Leverage
Peter T. Meinke, PhD
Sanders Director
In 2018, TDI is thrilled to welcome Dr. Peter T. Meinke as the new Sanders Director. Dr. Meinke is an industry veteran with extensive experience across all stages of drug discovery, from target validation through early clinical development. During his long tenure at Merck, his leadership produced one drug – the NS5A inhibitor, elbasvir, for the treatment of chronic hepatitis C – along with 13 development compounds that have advanced into the clinic in seven distinct therapeutic areas. In 2017, Dr. Meinke received the prestigious ACS Heroes of Chemistry Award in recognition of his contributions to the invention of elbasvir. He is co-author of over 90 peer-reviewed publications and co-inventor on more than 35 patents. Dr. Meinke also has significant international leadership experience: from 2008 to 2016, he worked and lived overseas in Shanghai, China, where he directed and mentored global drug discovery research teams while managing attendant business issues.
Current Members
Barry Coller, MD
David Rockefeller Professor
The Rockefeller University
Nathaniel Heintz, PhD
James and Marilyn Simons Professor,
Laboratory of Molecular Biology
The Rockefeller University
Barbara L. Hempstead, MD
Dean of the Weill Cornell Graduate School of Medical Sciences
Weill Cornell Medicine
Robert A Harrington, MD
Stephen and Suzanne Weiss Dean, Weill Cornell Medicine
Provost for Medical Affairs, Cornell University
Richard P. Lifton, MD, PhD
President
The Rockefeller University
Carl Nathan, MD
Chairman of Microbiology and Immunology
Weill Cornell Medicine
David Scheinberg, MD, PhD
Chairman, Experimental Therapeutics Center
Deputy Director, Sloan Kettering Institute for Therapeutic Discovery
Memorial Sloan Kettering Cancer Center
Derek Tan, PhD
Chair, Chemical Biology Program
Sloan Kettering Institute
Memorial Sloan Kettering Cancer Center
Selwyn Vickers, MD, FACS
President and Chief Executive Officer
Memorial Sloan Kettering Cancer Center
Emeritus
Augustine M. K. Choi, MD
Professor of Medicine
Weill Cornell Medicine
Laurie H. Glimcher, MD
President of Dana-Farber Cancer Institute
Marc Tessier-Lavigne, PhD
Bing Presidential Professor & Lab Head
Stanford University
Craig B. Thompson, MD
Lab Head, Memorial Sloan Kettering Cancer Institute
Francis Lee, MD
Mortimer D. Sackler, MD, Professor of Molecular Biology in Psychiatry
Mark Murcko, PhD
Founder & Board Member, Relay Therapeutics
Senior Lecturer, MIT
Mark Duggan, PhD
President, LifeSci Consulting, LLC
Vice President, Neuroscience, AstraZeneca
Joseph Vacca, PhD
President, Vacca Consulting, LLC
Fraser Glickman, PhD
Director, Fisher Drug Discovery Center
The Rockefeller University
Arvin Dar, PhD
Benno C. Schmidt Chair of Cancer Research
Memorial Sloan Kettering Cancer Center
Lorraine Gudas, PhD
Chair and Revlon Pharmaceutical Professor of Pharmacology and Toxicology of the Pharmacology Department
Weill Cornell Medicine
Matthew Moyle, PhD
CSO, Anaptys Bio, Inc.
Tomas Muselin, PhD
Division Head Rheumatology
University of Washington
Renier Brentjens, MD, PhD
Deputy Director and Chair of the Department of Medicine
Roswell Park Comprehensive Cancer Center
Sohail Tavazoie, MD, PhD
Leon Hess Professor and Sr. Attending Physician
The Rockefeller University
Charles Rudin, MD, PhD
Chief of the Thoracic Oncology Service
Memorial Slaon Kettering Cancer Center
Silvia Formenti, MD
Chair of Radiation Oncology
Weill Cornell Medicine